310 related articles for article (PubMed ID: 22287575)
21. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.
Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE
Diabetologia; 2010 Aug; 53(8):1761-71. PubMed ID: 20461358
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells.
Zhang L; Wu JH; Otto JC; Gurley SB; Hauser ER; Shenoy SK; Nagi K; Brian L; Wertman V; Mattocks N; Lawson JH; Freedman NJ
Cardiovasc Res; 2017 Nov; 113(13):1551-1559. PubMed ID: 29048463
[TBL] [Abstract][Full Text] [Related]
23. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
24. Nelumbo nucifera leaf extract inhibits neointimal hyperplasia through modulation of smooth muscle cell proliferation and migration.
Karki R; Jeon ER; Kim DW
Nutrition; 2013 Jan; 29(1):268-75. PubMed ID: 22959632
[TBL] [Abstract][Full Text] [Related]
25. Introduction of embryonic stem cells into vein grafts reduces intimal hyperplasia in mice.
Breuer S; Fogelstrand P; Lindskog H; Osterberg K; Luebke T; Brunkwall J; Mattsson E
J Cardiovasc Surg (Torino); 2014 Apr; 55(2):235-46. PubMed ID: 23369946
[TBL] [Abstract][Full Text] [Related]
26. Pyrogallol abates VSMC migration via modulation of Caveolin-1, matrix metalloproteinase and intima hyperplasia in carotid ligation mouse.
Ma YD; Thiyagarajan V; Tsai MJ; Lue SI; Chia YC; Shyue SK; Weng CF
Environ Toxicol Pharmacol; 2016 Dec; 48():63-75. PubMed ID: 27768988
[TBL] [Abstract][Full Text] [Related]
27. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.
Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW
EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791
[TBL] [Abstract][Full Text] [Related]
28. Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury.
Helkin A; Bruch D; Wilson DR; Gruessner AC; Bader RR; Maier KG; Gahtan V
Vasc Endovascular Surg; 2019 Jul; 53(5):379-386. PubMed ID: 30982448
[TBL] [Abstract][Full Text] [Related]
29. Endoluminal smooth muscle cell seeding limits intimal hyperplasia.
Gomes D; Louedec L; Plissonnier D; Dauge MC; Henin D; Osborne-Pellegrin M; Michel JB
J Vasc Surg; 2001 Oct; 34(4):707-15. PubMed ID: 11668328
[TBL] [Abstract][Full Text] [Related]
30. TNF-α promotes survival and migration of MSCs under oxidative stress via NF-κB pathway to attenuate intimal hyperplasia in vein grafts.
Bai X; Xi J; Bi Y; Zhao X; Bing W; Meng X; Liu Y; Zhu Z; Song G
J Cell Mol Med; 2017 Sep; 21(9):2077-2091. PubMed ID: 28266177
[TBL] [Abstract][Full Text] [Related]
31. bFGF release is dependent on flow conditions in experimental vein grafts.
Lepidi S; Sterpetti AV; Cucina A; Di Carlo A; Patrizi AL; Palumbo R; Bernucci P; Santoro-D'Angelo L; Cavallaro A
Eur J Vasc Endovasc Surg; 1995 Nov; 10(4):450-8. PubMed ID: 7489214
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
[TBL] [Abstract][Full Text] [Related]
33. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle-mediated local delivery of an antisense TGF-β1 construct inhibits intimal hyperplasia in autogenous vein grafts in rats.
Sun DX; Liu Z; Tan XD; Cui DX; Wang BS; Dai XW
PLoS One; 2012; 7(7):e41857. PubMed ID: 22860019
[TBL] [Abstract][Full Text] [Related]
35. Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway.
Sun HJ; Zhao MX; Ren XS; Liu TY; Chen Q; Li YH; Kang YM; Wang JJ; Zhu GQ
Antioxid Redox Signal; 2016 Jun; 24(18):1045-57. PubMed ID: 26952533
[TBL] [Abstract][Full Text] [Related]
36. Formation of myointimal hyperplasia and cytokine production in experimental vein grafts.
Sterpetti AV; Cucina A; Lepidi S; Randone B; Corvino V; D'Angelo LS; Cavallaro A
Surgery; 1998 Apr; 123(4):461-9. PubMed ID: 9551074
[TBL] [Abstract][Full Text] [Related]
37. Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells.
Zeller I; Knoflach M; Seubert A; Kreutmayer SB; Stelzmüller ME; Wallnoefer E; Blunder S; Frotschnig S; Messner B; Willeit J; Debbage P; Wick G; Kiechl S; Laufer G; Bernhard D
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1733-40. PubMed ID: 20595649
[TBL] [Abstract][Full Text] [Related]
38. Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Regulate the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia.
Liu R; Shen H; Ma J; Sun L; Wei M
Cardiovasc Drugs Ther; 2016 Apr; 30(2):111-8. PubMed ID: 26650931
[TBL] [Abstract][Full Text] [Related]
39. FSP-1 silencing in bone marrow cells suppresses neointima formation in vein graft.
Cheng J; Wang Y; Liang A; Jia L; Du J
Circ Res; 2012 Jan; 110(2):230-40. PubMed ID: 22116816
[TBL] [Abstract][Full Text] [Related]
40. Pioglitazone preserves vein graft integrity in a rat aortic interposition model.
Chen Z; Hasegawa T; Tanaka A; Okita Y; Okada K
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):408-416.e1. PubMed ID: 20189191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
